Abstract
H1 Supplementary Patent Certificate – Antibodies for use in the treatment of inflammatory diseases – Construction of art.3(a) of the SPC Regulation – Single active ingredient – Whether protected by basic patent – Whether infringement test applicable – Extent of invention – Whether protection available where active ingredient not specifically referred to – Whether functional definition sufficiently specific – Marketing authorisation obtained by third party – Reference to Court of Justice of the European Union – Interpretation of judgment of Court of Justice – Whether declaration appropriate
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
